These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37327258)

  • 81. [
    Sollini M; Trenti N; Malagoli E; Catalano M; Di Mento L; Kirienko A; Berlusconi M; Chiti A; Antunovic L
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1605-1615. PubMed ID: 31044264
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The role of early 18F-FDG PET/CT in therapeutic management and ongoing risk stratification of high/intermediate-risk thyroid carcinoma.
    Triviño Ibáñez EM; Muros MA; Torres Vela E; Llamas Elvira JM
    Endocrine; 2016 Mar; 51(3):490-8. PubMed ID: 26224589
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The value of [18F]FDG PET/CT examination in the detection and differentiation of recurrent ovarian cancer.
    Kosinska M; Misiewicz P; Kalita K; Fijuth J; Foks M; Kuncman L; Gottwald L
    Nucl Med Rev Cent East Eur; 2023; 26(0):98-105. PubMed ID: 37525539
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical and Prognostic Value of
    Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P
    Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study.
    Sollini M; Morbelli S; Ciccarelli M; Cecconi M; Aghemo A; Morelli P; Chiola S; Gelardi F; Chiti A
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3187-3197. PubMed ID: 33677642
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model.
    Kim Y; Lee HY; Yoon HJ; Kim BS
    J Craniomaxillofac Surg; 2016 Apr; 44(4):357-63. PubMed ID: 26880011
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Assessment of biological parameters in head and neck cancer based on in vivo distribution of
    Cegla P; Kazmierska J; Gwozdz S; Czepczynski R; Malicki J; Cholewinski W
    Tumori; 2020 Feb; 106(1):33-38. PubMed ID: 31446858
    [TBL] [Abstract][Full Text] [Related]  

  • 88. FDG-PET/CT for diagnosis and follow-up of necrotizing (malignant) external otitis.
    Stern Shavit S; Bernstine H; Sopov V; Nageris B; Hilly O
    Laryngoscope; 2019 Apr; 129(4):961-966. PubMed ID: 30549258
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.
    Xu F; Liu F; Pastakia B
    Clin Nucl Med; 2014 Sep; 39(9):e407-9. PubMed ID: 24217536
    [TBL] [Abstract][Full Text] [Related]  

  • 90. 18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.
    Albano D; Bosio G; Treglia G; Giubbini R; Bertagna F
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):77-84. PubMed ID: 28822997
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly.
    Gu X; Liu R
    Clin Interv Aging; 2016; 11():1365-1370. PubMed ID: 27729779
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival.
    Valerio L; Guidoccio F; Giani C; Tardelli E; Puccini G; Puleo L; Minaldi E; Boni G; Elisei R; Volterrani D
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2355-2366. PubMed ID: 33901285
    [TBL] [Abstract][Full Text] [Related]  

  • 93. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
    Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
    BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
    Kumar R; Hawkins RA; Yeh BM; Wang ZJ
    Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
    Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H
    Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
    Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
    Blood; 1999 Jul; 94(2):429-33. PubMed ID: 10397709
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
    Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K
    World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Increased Accumulation of 18F-FDG Incidentally Observed in Hyperacute Cerebral Infarction.
    Sotome W; Ito Y; Higuchi N; Asami Y; Satomi N
    Clin Nucl Med; 2022 May; 47(5):439-440. PubMed ID: 35025813
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Bilateral Testicular Mass Presenting as a Rare Manifestation of Extramedullary Plasmacytoma on 18F-FDG PET/CT.
    Civan C; Apaydin Arikan E; Has Simsek D; Sanli O; Kuyumcu S
    Clin Nucl Med; 2022 Mar; 47(3):e296-e297. PubMed ID: 35025778
    [TBL] [Abstract][Full Text] [Related]  

  • 100. 18F-FDG PET/CT in early phase of sporadic Creutzfeldt-Jacob disease: A case report.
    Boero G; Lauriero F; Fusillo D; Calvello R; Cianciulli A; Panaro MA; Moda P
    Clin Case Rep; 2024 Jul; 12(7):e8974. PubMed ID: 38947537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.